Jones Financial Companies
FLNA

Jones Financial Companies’s Filana Therapeutics FLNA Stock Holding History

Jones Financial Companies’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$772 Buy
462
+67
+17% +$138 ﹤0.01% 4412
2025
Q4 		$782 Sell
395
-103
-21% -$330 ﹤0.01% 4073
2025
Q3 		$1.49K Buy
498
+100
+25% +$230 ﹤0.01% 3785
2025
Q2 		$697 Hold
398
– – ﹤0.01% 3741
2025
Q1 		$657 Hold
398
– – ﹤0.01% 3479
2024
Q4 		$939 Sell
398
-3,155
-89% -$55.4K ﹤0.01% 3153
2024
Q3 		$101K Buy
3,553
+2,350
+195% +$54.1K ﹤0.01% 1400
2024
Q2 		$14.9K Buy
+1,203
New +$25.4K ﹤0.01% 1629

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jones Financial Companies's FLNA Position: Q1 2026 in Review

Jones Financial Companies increased its Filana Therapeutics (FLNA) stake by 17% in Q1 2026, buying an estimated $138 and bringing the position to 462 shares worth $772. The position accounts for ﹤0.01% of the portfolio, ranked #4412.

Jones Financial Companies first reported a position in FLNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $101K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Jones Financial Companies held 462 shares of Filana Therapeutics worth $772 as of Q1 2026.
  • Jones Financial Companies bought 67 Filana Therapeutics shares in Q1 2026, an estimated $138.
  • Filana Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4412 holding.
  • Jones Financial Companies first reported a position in Filana Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Filana Therapeutics position peaked at $101K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.